Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ru Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117700326A reveals a novel Ruthenium catalyst for carbamate hydrogenation. This breakthrough enables cost reduction in fine chemical manufacturing and reliable supply chains.
Advanced ruthenium catalyst technology for cyclic carbonate hydrogenation. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN103502208B reveals mild diamine synthesis avoiding Birch reduction. Enables cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN110655480A reveals a green Ru/C-catalyzed oxidation method for sulfones. Achieve near-quantitative yields in water, offering significant cost reduction and supply chain reliability.
Patent CN110294689B details a green ruthenium-catalyzed method for converting primary amines to nitriles with high yield and hydrogen byproduct.
Novel copper-catalyzed substitution route for efficient ligand production enabling high-performance ruthenium dehydrogenation catalysts for pharmaceutical applications.
Patent CN111892528A details a regioselective Ru-catalyzed C-H amidation method, offering cost-effective routes for high-purity pharmaceutical intermediates and scalable API manufacturing.
Patent CN112675920B reveals a novel monochiral ruthenium catalyst enabling efficient asymmetric hydrogenation and kinetic resolution for high-purity pharmaceutical intermediates.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN111468191A details a safe, scalable phosphorus ylide route for Grubbs catalysts, offering cost reduction and supply chain stability for fine chemical manufacturing.
Discover how novel biphenyl-type tridentate ligand ruthenium complexes enable ester-to-alcohol hydrogenation at 60-100°C and 3-10MPa, reducing costs and safety risks for pharma production.
Discover how ruthenium-catalyzed 3+2 cycloaddition enables efficient, single-step pyrrole synthesis with 50-71% yields, reducing multi-step costs and supply chain risks for pharmaceutical intermediates.
Discover how chiral phosphoric acid catalysis enables high-yield, enantioselective synthesis of axial chiral aryl indoles for cancer drug development and supply chain de-risking.